3rd Jan 2014 09:39
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.07 per Ordinary Share, and notional ADSs at a price of $53.17 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2013 to 31 December 2013:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,644.680 | |
Professor Sir Roy Anderson | 563.939 | |
Dr Stephanie Burns |
| 320.928 |
Stacey Cartwright | 447.262 | |
Lynn Elsenhans | 577.671 | |
Judy Lewent | 311.489 | |
Sir Deryck Maughan | 868.394 | |
Dr Daniel Podolsky | 651.295 | |
Tom de Swaan | 408.370 | |
Jing Ulrich | 217.098 | |
Hans Wijers | 447.262 | |
Sir Robert Wilson | 447.262 | |
The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Sonja Arsenić
Corporate Secretariat
3 January 2014
Related Shares:
Glaxosmithkline